Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae
Authors:
Open Access
- 8 December 2017
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-12
Abstract
Emerging multidrug-resistant bacteria are a challenge for modern medicine, but how these pathogens are so successful is not fully understood. Robust antibacterial vaccines have prevented and reduced resistance suggesting a pivotal role for immunity in deterring antibiotic resistance. Here, we show the increased prevalence ofKlebsiella pneumoniaelipopolysaccharide O2 serotype strains in all major drug resistance groups correlating with a paucity of anti-O2 antibodies in human B cell repertoires. We identify human monoclonal antibodies to O-antigens that are highly protective in mouse models of infection, even against heavily encapsulated strains. These antibodies, including a rare anti-O2 specific antibody, synergistically protect against drug-resistant strains in adjunctive therapy with meropenem, a standard-of-care antibiotic, confirming the importance of immune assistance in antibiotic therapy. These findings support an antibody-based immunotherapeutic strategy even for highly resistantK. pneumoniaeinfections, and underscore the effect humoral immunity has on evolving drug resistance.Keywords
This publication has 54 references indexed in Scilit:
- Lipopolysaccharide Modifications of a Cholera Vaccine Candidate Based on Outer Membrane Vesicles Reduce Endotoxicity and Reveal the Major Protective AntigenInfection and Immunity, 2013
- Sustained Protection in Mice Immunized with Fractional Doses of Salmonella Enteritidis Core and O Polysaccharide-Flagellin GlycoconjugatesPLOS ONE, 2013
- PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa-infected miceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing ActivityCell Host & Microbe, 2010
- Resilience to Bacterial Infection: Difference between Species Could Be Due to Proteins in SerumThe Journal of Infectious Diseases, 2010
- Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258Antimicrobial Agents and Chemotherapy, 2009
- Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningJournal of Immunological Methods, 2008
- Klebsiella pneumoniae Genotype K1: An Emerging Pathogen That Causes Septic Ocular or Central Nervous System Complications from Pyogenic Liver AbscessClinical Infectious Diseases, 2007
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Bactericidal Reaction of Mouse SerumScience, 1956